These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 3301895

  • 41. Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D, and E toxins and tetanus toxin.
    Tsuzuki K, Yokosawa N, Syuto B, Ohishi I, Fujii N, Kimura K, Oguma K.
    Infect Immun; 1988 Apr; 56(4):898-902. PubMed ID: 2450068
    [Abstract] [Full Text] [Related]

  • 42. Development of antitoxin with each of two complementary fragments of Clostridium botulinum type B derivative toxin.
    Kozaki S, Miyazaki S, Sakaguchi G.
    Infect Immun; 1977 Dec; 18(3):761-6. PubMed ID: 412790
    [Abstract] [Full Text] [Related]

  • 43. Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay.
    Shone C, Wilton-Smith P, Appleton N, Hambleton P, Modi N, Gatley S, Melling J.
    Appl Environ Microbiol; 1985 Jul; 50(1):63-7. PubMed ID: 3927840
    [Abstract] [Full Text] [Related]

  • 44. Studies on immunity to toxins of Clostridium botulinum. VI. Purification and detoxification of type D toxin and the immunological response to toxoid.
    CARDELLA MA, DUFF JT, WINGFIELD BH, GOTTFRIED C.
    J Bacteriol; 1960 Mar; 79(3):372-8. PubMed ID: 13807649
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Enhancing toxin-based vaccines against botulism.
    Przedpelski A, Tepp WH, Zuverink M, Johnson EA, Pellet S, Barbieri JT.
    Vaccine; 2018 Feb 01; 36(6):827-832. PubMed ID: 29307477
    [Abstract] [Full Text] [Related]

  • 49. Evaluation of a monoclonal antibody-based immunoassay for detecting type B Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat system.
    Gibson AM, Modi NK, Roberts TA, Hambleton P, Melling J.
    J Appl Bacteriol; 1988 Apr 01; 64(4):285-91. PubMed ID: 3049499
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.
    Fan Y, Barash JR, Lou J, Conrad F, Marks JD, Arnon SS.
    J Infect Dis; 2016 May 15; 213(10):1606-14. PubMed ID: 26936913
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Identification of strain B 657 of Clostridium botulinum].
    Giménez DF, Giménez JA.
    Rev Argent Microbiol; 1983 May 15; 15(1):51-5. PubMed ID: 6400761
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Clostridium botulinum type E toxin and toxoid.
    BARRON AL, REED GB.
    Can J Microbiol; 1954 Oct 15; 1(2):108-17. PubMed ID: 14352045
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.